Research & Case Study Reports

My Research & Case Studies, Requests for Research Participants, References for this site, Research Organisations

 

MY RESEARCH & CASE STUDIES

REFERENCES RELATED TO THIS WEBSITE

AUTISM RESEARCH CENTRES WEBSITES & LINKS 

 

Some of my Case Study Research

Assemblage Point Alignment

July 2016
Case Study Gender: Male
Case Study Diagnosis: Learning Disability & Generalised Anxiety Disorder
 
I realigned a client's AP whilst with him a few weeks ago and when I revisited him this week he was talking very fast and his overall behaviour was hyper. On rechecking, his AP had started to move back but not as far as it was nor split as it was when I originally realigned it. He continued chatting to me while I realigned it and his voice noticably got deeper and his speed of talking noticably slowed down as I was working with him and his energy auras. This was incredible to witness and he actually agreed to remove his shoes and let me massage his feet this week whereas last week he wouldn't do this and was adverse to not wearing his shoes arund his flat, so I massaged his ankles and used the OM tuning fork to support grounding him after his initial AP realignment. This week however, after initially not being keen before the alignment to remove his shoes, he put his feet on my lap individually and let me massage his feet thoroughly. He assured me he had rested on his bed for 20 minutes after I had left the week before and would do this again after I left this week.
He has made significant progress whilst I have been working with him this last year, initially using NLP to adddress his anxiety and enable and empower him to leave his room more often and socialise with the other house residents. More recently introducing and using sound healing (tuning forks, gongs, bells, flute etc. - he has not been quite ready yet for me to use my voice  sounding on him) but as he is now allowing more physical contact and lets me get closer to him with the sound instruments and we have a good rapport and professional trusting relationship.
He doesn't have a diagnosis of autism but his family believe he does have autism and it has been over looked with the diagnosis he has had since he has been a young boy, as do I but there is no additional advantage at the moment to having him assessed for an ASD diagnosis.
July 2016
Case Study for Distance Assemblage Point Alignment Realignment
Case Study Gender: Female
Distance: In same city as me, Bristol
Case Study Diagnosis: No ASD but Artheritis, Diabetes, Hip Pain, Anaemia
Despite it being generally believed that moving the AP at a distance is not possible, I have been exploring this possibility and have several case studies who are receiving AP alignment from a distance. To date, I have 3 case studies, one in Bristol, one in London and one in Canada. I have recently visited this one in Bristol and when checking the position of her assemblage point physically after aligning it the week before at a distanceit was still in its correct location as were all her energy bodies, the etheric, astral and causual bodies. The client's AP had been split and in lower positions on her body when initially checked at a distance. I had realigned everything for her.
The client is usually very tired and drawn in appearance and often when learning to use a new mobile phone, gets very impatient with herself. However, whilst helping her use more features this week on her new phone ( which is her first experience of anything computerised) she was much more calmer and more patient as she was learning a new skill to type and how to send an email.
This case is the first I have done which has shown that realigning the AP at a distance is in fact possible.

 

 

 

UK AUTISM RESEARCH CENTRES:

Participants invited to register and welcomed...

Wales Autism Research Centre: Prof. Sue Leekam, Director & UK Chair in Autism

Cambridge Autism Research Centre: Professor Simon Baron-Cohen, Director

Autism Research Trust: Professor Simon Baron-Cohen, Trustee

Research Autism: National Autistic Society

 

References for citations on this website are:

 

ABRAHAMS, B.S. and GESCHWIND, D.H. 2008. Advances in autism genetics: on the threshold of a new neurobiology. Nature Reviews Genetics, 9(5), 341-355.

ADAMS, J. 2007.Results of a DMSA treatment study: ARI video. [online video]. http://www.autism.com/families/videos.htm (17 March 2010).

ADAMS, J., BARAL, M., GEIS, E., MITCHELL, J., INGRAM, J., HENSLEY, A., ZAPPIA, I., NEWMARK, S., GEHN, E., RUBIN, R., MITCHELL, K., BRADSTREET, J. and EL-DAHR, J. 2009a.Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part A - medical results.[WWW]. http://www.biomedcentral.com/1472-6904/9/16  (14 March 2010).

ADAMS, J., BARAL, M., GEIS, E., MITCHELL, J., INGRAM, J., HENSLEY, A., ZAPPIA, I., NEWMARK, S., GEHN, E., RUBIN, R., MITCHELL, K., BRADSTREET, J. and EL-DAHR, J. 2009b.Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results.[WWW].http://www.biomedcentral.com/1472-6904/9/17  (14 March 2010).

AMERICAN ACADEMY OF PEDIATRICS (AAP) 1999. Thimerosal in Vaccines: a Joint Statement of the American Academy of Pediatrics and the Public.Centers for Disease Control & Prevention (CDC).

AMERICAN PSYCHIATRIC ASSOCIATION 2000. Diagnostic and statistical manual of mental disorders : DSM-IV-TR . 4th rev edn. American Psychiatric Association Washington DC.

AMERICAN PSYCHIATRIC ASSOCIATION 1994. Diagnostic and statistical manual of mental disorders : DSM-IV . 4th edn. Washington DC: American Psychiatric Association.

ANDREWS, N., MILLER, E., TAYLOR, B., LINGAM, R., SIMMONS, A., STOWE, J. and WAIGHT, P. 2002. Recall bias, MMR, and autism. Archives of Disease in Childhood, 87(6), 493-494.

ARTIGAS-PALLARÉS, J. 2010. [Autism and vaccinations: the end?]. Revista de neurologia, 50 Suppl 3, S91-S99.

AUTISM GENOME PROJECT (AGP). 2009. AGP Research: Phase 1 Project.[WWW]. http://www.autismgenome.org/research/phase1.htm  (10 January 2010).

AUTISM RESEARCH INSTITUTE (ARI). 2010. Triggers of autism.[WWW]. http://www.autism.com/faq_triggers_of_autism.asp  (6 December 2010).

AUTISM SOCIETY OF AMERICA (ASA).2010. Autism and vaccines.[WWW].http://www.autism-society.org/site/PageServer?pagename=research_envirohealth_vaccines  (6 December 2010).

AUTISM SOCIETY OF AMERICA (ASA).2010. Environmental health and autism.[WWW].http://www.autism-society.org/site/PageServer?pagename=research_envirohealth  (6 December 2010).

AUTISM SOCIETY OF AMERICA (ASA). 2010. History.[WWW].http://www.autism-society.org/site/PageServer?pagename=asa_princip_history  (20 December 2010).

AUTISM SPEAKS.2010. Autism speaks, leadership, board members.[WWW]. http://www.autismspeaks.org/board.php  (13 December 2010).

BAILEY, A., LE COUTEUR, A., GOTTESMAN, I., BOLTON, P., SIMONOFF, E., YUZDA, E. and RUTTER, M. 1995. Autism as a strongly genetic disorder: evidence from a British twin study. ENGLAND.

BAKER, J. 2008. Mercury, Vaccines and Autism: One Controversy, Three Histories. Pubic Health Then and Now, 98(2), 244-245-253.

BALL, L.K., BALL, R. and PRATT, R.D. 2001. An Assessment of Thimerosal Use in Childhood Vaccines. Pediatrics, 107(5), 1147.

BARON-COHEN, S. 2008. Autism and Asperger Syndrome, the facts. . First Edition edn. United States: Oxford University Press Inc., New York.

BARON-COHEN, S., SCOTT, F., ALLISON, C., WILLIAMS, J., BOLTON, B., MATTHEWS, F. and BRAYNE, C. 2009. Prevalence of autism-spectrum conditions:: Uk School based population study. The British Journal of Psychiatry, 194, 500-501-509.

BARRETT, S. 2006. Edelson center closed after three suits alleging fraud and malpractice.2006. [WWW].http://www.quackwatch.org/11Ind/edelson.html  (22 March 2010).

BERNARD, S., ENAYATI, A., BINSTOCK, T., ROGER, H., REDWOOD, L. and MCGINNIS, W.2000. Autism: A unique type of mercury poisoning.[WWW]. http://www.safeminds.org/about/documents/SM%20Autism-Mercury%20Paper%20Long%20Version.pdf  (22 February 2014).

BERNARD, S., ENAYATI, A., REDWOOD, L., ROGER, H., BINSTOCK, T. 2001. Autism: a novel form of mercury poisoning. Medical Hypotheses, 56(4), 462-471.

BERNARD, S., ENAYATI, A., ROGER, H., BINSTOCK, T. and REDWOOD, L. 2002. The role of mercury in the pathogenesis of autism. Molecular psychiatry, 7(3), 42.

BIGHAM, M. and COPES, R. 2005. Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease. Drug Safety: An International Journal Of Medical Toxicology And Drug Experience, 28(2), 89-101.

BLACK, R. 2010. Rare genetic patterns found to be associated with autism suggest gene therapy could treat disorder. [WWW]. http://www.nydailynews.com/lifestyle/health/2010/06/10/2010-06-10_rare_genetic_patterns_found_to_be_associated_with_autism_suggest_gene_therapy_co.html  (16 November 2010).

BLAXILL, M.E. 2004. Study Fails To Establish Diagnostic Substitution as a Factor in Increased Rate of Autism. Pharmacotherapy, 24(6), 812-815.

BLAXILL, M.F. 2004. What's going on? The question of time trends in autism. Public Health Reports (Washington, D.C.: 1974), 119(6), 536-551.

BLAXILL, M.F., REDWOOD, L. and BERNARD, S. 2004. Thimerosal and autism? A plausible hypothesis that should not be dismissed. Medical hypotheses, 62(5), 788-794.

BRITISH BROADCASTING COMPANY (BBC) NEWS.2005. Blood 'fast' to expel jab mercury. [online news]. http://news.bbc.co.uk/1/hi/health/4472485.stm  (20 December 2010).

BURBACHER, T.M., SHEN, D.D., LIBERATO, N., GRANT, K.S., CERNICHIARI, E. and CLARKSON, T. 2005. Comparison of Blood and Brain Mercury Levels in Infant Monkeys Exposed to Methylmercury or Vaccines Containing Thimerosal. Environmental health perspectives, 113(8), 1015-1021.

BURGESS, D.C., BURGESS, M.A. and LEASK, J. 2006. The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication? Vaccine, 24(18), 3921-3928.

BUTTRAM, H.2010. Measles-mumps-rubella (MMR) vaccine as a potential cause of encephalitis (brain inflammation) in children.[WWW]. http://www.whale.to/v/buttram.html  (27 December 2010).

CASSIDY, A. McCONKEY, R. TRUESDALE-KENNEDY, M.SLEVIN, E. 2008. Pre-schoolers with autism spectrum disorders: the impact on families and the supports available to them. Early Child Development and Care, 178 (2).pp.115-128.

CHEN, W., LANDAU, S., SHAM, P. and FOMBONNE, E. 2004. No evidence for links between autism, MMR and measles virus. Psychological medicine, 34(3), 543-553.

CLEMENTS, C.J. 2004. The evidence for the safety of thiomersal in newborn and infant vaccines. Vaccine, 22(15-16), 1854-1861.

CLEMENTS, C.J. and MCINTYRE, P.B. 2006. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines. Expert opinion on drug safety, 5(1), 17-29.

COHLY, H.H. and PANJA, A. 2005. Immunological findings in autism. International review of neurobiology, 71, 317-341.

DEMYER, M.K. 1981. Infantile Autism Reviewed: A Decade of Research. Schizophr Bull, 7, 388-451.

DEPARTMENT OF HEALTH (DOH).2003. Thiomersal and vaccines.[WWW]. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4070148 (12/18/2010).

DESOTO, M.C. and HITLAN, R.T. 2007. Blood Levels of Mercury Are Related to Diagnosis of Autism: A Reanalysis of an Important Data Set. Journal of child neurology, 22(11), 1308-1311.

DYER, C. 2010. Thiomersal in vaccines does not cause autism, US claims court finds. BMJ: British Medical Journal, 340(7747), 613-613.

DYER, O. 2007. Andrew Wakefield is accused of paying children for blood samples. BMJ (Clinical research ed.), 335(7611), 118-119.

EGGERTSON, L. 2010. Lancet retracts 12-year-old article linking autism to MMR vaccines. CMAJ: Canadian Medical Association Journal, 182, E199-E200.

FAGAN, G., PRITCHARD, S., CLARKSON, T. and GREENWOOD, M. 1977. Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic. ENGLAND: .

FEINSTEIN, A. 2010. A history of Autism: Conversations with the Pioneers. 1 edn. United Kingdom: Wiley-Blackwell.

FOLB, P.I., BERNATOWSKA, E., CHEN, R., CLEMENS, J., DODOO, A.N.O., ELLENBERG, S.S., FARRINGTON, C.P., JOHN, T.J., LAMBERT, P., MACDONALD, N.E., MILLER, E., SALISBURY, D., SCHMITT, H., SIEGRIST, C. and WIMALARATNE, O. 2004. A Global Perspective on Vaccine Safety and Public Health: The Global Advisory Committee on Vaccine Safety. American Journal of Public Health, 94(11), 1926-1931.

FOLSTEIN, S. and RUTTER, M. 1977. Infantile Autism: a Genetic Study of 21 Twin Pairs.

FOMBONNE, E. and CHAKRABARTI, S. 2001. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics, 108(4), E58-E58.

FEUSTELL, B. & WOODSMALL, W. 2001. Modelling with NLP: Capturing and Transferring Expertise in Organisations. [WWW] http//:www.cnlpa.de/downloads/Fachartikel/2002-07-modeling-with-nlp.pdf (accessed 21 September 2014)

GEIER, M. and GEIER, D. 2003. Thimerosal in Childhood Vaccines, Neurodevelopmental Disorders, and Heart Disease in the United States. Journal of American Physicians and Surgeons, 8(1), 6-7-11.

GEIER, D., YOUNG, H. and GEIER, M. 2010. Thimerosal exposure & increasing trends of premature puberty in the vaccine safety datalink. The Indian journal of medical research, 131, 500-507.

GEIER, D.A., KING, P.G. and GEIER, M.R. 2009. Mitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure to thimerosal and other metal compounds. Toxicological & Environmental Chemistry, 91(4), 735 <last_page> 749.

GEIER, D.A. and GEIER, M.R. 2006. A Clinical and Laboratory Evaluation of Methionine Cycle-Transsulfuration and Androgen Pathway Markers in Children with Autistic Disorders. Hormone research, 66(4), 182-188.

GEIER, D.A. and GEIER, M.R. 2004. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Medical Science Monitor: International Medical Journal Of Experimental And Clinical Research, 10(3), PI33-PI39.

GEIER, D.A., JORDAN, S.K. and GEIER, M.R. 2010. The relative toxicity of compounds used as preservatives in vaccines and biologics. Medical Science Monitor: International Medical Journal Of Experimental And Clinical Research, 16(5), SR21-SR27.

GEIER, D.A., SYKES, L.K. and GEIER, M.R. 2007. A Review of Thimerosal (Merthiolate) and its Ethylmercury Breakdown Product: Specific Historical Considerations Regarding Safety and Effectiveness. Journal of Toxicology & Environmental Health: Part B, 10(8), 575-596.

GEIER, M.R. and GEIER, D.A. 2005. The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. Medical hypotheses, 64(5), 946-954.

GENECARDS.2010. AGTR2 gene - GeneCards | AGTR2 protein | AGTR2 antibody.[WWW]. http://www.genecards.org/cgi-bin/carddisp.pl?gene=AGTR2&search=AGTR2  (7 November 2010).

GENECARDS.2010.C9orf156 gene - GeneCards | NAP1 protein | NAP1 antibody.[WWW].http://www.genecards.org/cgi-bin/carddisp.pl?gc_id=GC09M100666  (15 November 2010).

GENECARDS.2010. CADPS2 gene - GeneCards | CAPS2 protein | CAPS2 antibody.[WWW]. http://www.genecards.org/cgi-bin/carddisp.pl?gene=CADPS2&search=CADPS2  (7 November 2010).

GENECARDS.2010. DLGAP2 gene - GeneCards | DLGP2 protein | DLGP2 antibody. [WWW]. http://www.genecards.org/cgi-bin/carddisp.pl?gene=Dlgap2  (31 October 2010).

GENECARDS.2010. FOXP2 gene - GeneCards | FOXP2 protein | FOXP2 antibody. [WWW]. http://www.genecards.org/cgi-bin/carddisp.pl?gene=FOXP2&search=FOXP2  (7 November 2010).

GENECARDS.2010. GRM8 gene - GeneCards | GRM8 protein | GRM8 antibody.[WWW]. http://www.genecards.org/cgi-bin/carddisp.pl?gene=GRM8&search=GRM8  (7 November 2010).

GENECARDS.2010. IMMP2L gene - GeneCards | IMP2L protein | IMP2L antibody.[WWW]. http://www.genecards.org/cgi-bin/carddisp.pl?gene=immp2l  (24 October 2010).

GENECARDS.2010. MECP2 gene - GeneCards | MECP2 protein | MECP2 antibody.[WWW]. http://www.genecards.org/cgi-bin/carddisp.pl?gene=MECP2&search=mecp2  (11 November 2010).

GENECARDS.2010. SEMA5A gene - GeneCards | SEM5A protein | SEM5A antibody.[WWW]. http://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA5A  (28 October 2010).

GENECARDS.2010. SYNGAP1 gene - GeneCards | SYGP1 protein | SYGP1 antibody.[WWW]. http://www.genecards.org/cgi-bin/carddisp.pl?gene=Syngap1  (31 October 2010).

GENECARDS.2010. WNT2 gene - GeneCards | WNT2 protein | WNT2 antibody.[WWW]. http://www.genecards.org/cgi-bin/carddisp.pl?gene=Wnt2  (7 November 2010).

GENETICS HOME REFERENCE (GHR).2010. 47,XYY syndrome.[WWW]. http://ghr.nlm.nih.gov/condition/47xyy-syndrome  (4 November 2010).

GENETICS HOME REFERENCE (GHR).2010. 5-HTT.[WWW]. http://ghr.nlm.nih.gov/search?query=5-HTT&Search=  (12 November 2010).

GENETICS HOME REFERENCE (GHR).2010. ATP gene family.[WWW]. http://ghr.nlm.nih.gov/geneFamily/atp  (24 October 2010).

GENETICS HOME REFERENCE (GHR).2010. Chromosome 15.[WWW]. http://ghr.nlm.nih.gov/chromosome/15  (24 October 2010).

GENETICS HOME REFERENCE (GHR).2010. Chromosome 16.[WWW]. http://ghr.nlm.nih.gov/chromosome/16  (7 November 2010).

GENETICS HOME REFERENCE (GHR).2010. Chromosome 17.[WWW]. http://ghr.nlm.nih.gov/chromosome/17  (24 October 2010).

GENETICS HOME REFERENCE (GHR).2010. Chromosome 17.[WWW]. http://ghr.nlm.nih.gov/chromosome/17  (7 November 2010).

GENETICS HOME REFERENCE (GHR).2010. Chromosome 2.[WWW]. http://ghr.nlm.nih.gov/chromosome/2  (7 November 2010).

GENETICS HOME REFERENCE (GHR).2010. Chromosome 3 - conditions related to genes on chromosome 3.[WWW]. http://ghr.nlm.nih.gov/chromosome/3/show/Conditions  (24 October 2010).

GENETICS HOME REFERENCE (GHR).2010. Chromosome 7. [WWW]. http://ghr.nlm.nih.gov/chromosome/7  (7 November 2010).

GENETICS HOME REFERENCE (GHR).2010. FOXP2 - forkhead box P2.[WWW]. http://ghr.nlm.nih.gov/gene/FOXP2  (24 October 2010).

GENETICS HOME REFERENCE (GHR).2010. GABRA1 - gamma-aminobutyric acid (GABA) A receptor, alpha 1.[WWW]. http://ghr.nlm.nih.gov/gene/GABRA1  (24 October 2010).

GENETICS HOME REFERENCE (GHR).2010. MECP2 - methyl CpG binding protein 2 (rett syndrome).[WWW]. http://ghr.nlm.nih.gov/gene/MECP2  (24 October 2010).

GENETICS HOME REFERENCE (GHR).2010. MTHFR - 5,10-methylenetetrahydrofolate reductase (NADPH).[WWW]. http://ghr.nlm.nih.gov/gene/MTHFR  (30 July 2010).

GENETICS HOME REFERENCE (GHR).2010. RELN - reelin.[WWW]. http://ghr.nlm.nih.gov/gene/RELN  (24 October 2010).

GENETICS HOME REFERENCE (GHR).2010. SLC6A4 - solute carrier family 6 (neurotransmitter transporter, serotonin), member 4.[WWW]. http://ghr.nlm.nih.gov/gene/SLC6A4  (24 October 2010).

GENETICS HOME REFERENCE (GHR).2010. UBE3A - ubiquitin protein ligase E3A.[WWW]. http://ghr.nlm.nih.gov/gene/UBE3A  (24 October 2010).

GERBER, J. and OFFIT, P. 2009. Vaccines and autism: a tale of shifting hypotheses. Clinical Infectious Diseases: An Official Publication Of The Infectious Diseases Society Of America, 48(4), 456-461.

GILLBERG, C. and HEIJBEL, H. 1998. MMR and autism. SAGE Publications, 2(4), 423-424.

GILLBERG, C. 1992. Subgroups in autism: are there behavioural phenotypes typical of underlying medical conditions? Journal of intellectual disability research : JIDR, 36 ( Pt 3)(Pt 3), 201-214.

GRICE, A.2010. Blair's baby was given MMR vaccine last week. [WWW]. http://www.independent.co.uk/life-style/health-and-families/health-news/blairs-baby-was-given-mmr-vaccine-last-week-659152.html  (27 December 2010).

GUILLAUME, L. and BATH, P. 2008. A content analysis of mass media sources in relation to the MMR vaccine scare. Health Informatics Journal, 14(4), 323-334.

GUY, J., GAN, J., SELFRIDGE, J., COBB, S. and BIRD, A. 2007. Reversal of Neurological Defects in a Mouse Model of Rett Syndrome.

HALL, J.G. 2003. Twinning. Lancet, 362(9385), 735-743.

HARRIS, G. and O'CONNOR, A. 2005. On Autism's cause, Its parents vs Research. [Online Newspaper]. New York Times Online, Science.

HEBERT, E. and KOULOUGLIOTI, C. 2010. Parental Beliefs About Cause and Course of their Child's Autism and Outcomes of their Beliefs: A Review of the Literature. Issues in comprehensive pediatric nursing, 33(3), 149-163.

HERON, J., GOLDING, J. 2004. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics, 114(3), 577-583.

HERTZ-PICCIOTTO, I., CROEN, L.A., HANSEN, R., JONES, C.R., WATER, V.D. and PESSAH, I.N. 2006. The CHARGE Study: An Epidemiologic Investigation of Genetic and Environmental Factors Contributing to Autism. Environmental health perspectives, 114(7), 1119-1125.

HESSEL, L. 2003. Mercury in vaccines. Bulletin de l'Academie nationale de medecine, 187(8), 1501-1510.

HILARIO, J.; RODINO-KLAPAC, L.; WANG, C.; BEATTIE, C. 2009. Semaphorin 5A is a bifunctional axon guidance cue for axial motorneurons in vivo. Developmental Biology, 326(1),190-200.

HJALGRIM, H., GRØNSKOV, K. and BRØNDUM-NIELSEN, K. 1998. [Fragile X syndrome. Diagnosis, genetics and clinical findings]. Ugeskrift for laeger, 160(37), 5330-5334.

HONDA, H., SHIMIZU, Y. and RUTTER, M. 2005. No effect of MMR withdrawal on the incidence of autism: a total population study. Journal of Child Psychology & Psychiatry, 46(6), 572-579.

HORWITZ, A.V., VIDEON, T.M., SCHMITZ, M.F. and DAVIS, D. 2003. Rethinking twins and environments: possible social sources for assumed genetic influences in twin research. Journal of health and social behavior, 44(2), 111-129.

HOWLIN, P.1998.Children with Autism and Asperger Syndrome. A Guide for Practitioners and Carers. 5th ed. Chichester, England, UK. John Wiley & Sons Ltd.

HOWSON, C.P., HOWE, C.J. and FINEBERG, H.V. 1991. Adverse effects of pertussis and rubella vaccines: a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines Washington, D.C.: National Academy Press.

HUGHES, J.R. 2008. A review of recent reports on autism: 1000 studies published in 2007. Epilepsy & Behavior, 13(3), 425-437.

JUSTICE, AWARENESS AND BASIC SUPPORT (JABS).2010. JABS welcome page.[WWW]. http://www.jabs.org.uk/pages/about.asp  (20 December 2010).

LAURANCE, J.2007. Autism: what are the ethics of treating disability? - health news, health & families. The Independent. [online newspaper].http://www.independent.co.uk/life-style/health-and-families/health-news/autism-what-are-the-ethics-of-treating-disability-400568.html  (17 December 2010).

LAURANCE, J.2009. , the big question: should mothers be offered screening for autism, and what issues would it raise? - big question, extras. The Independent.[online newspaper]. http://www.independent.co.uk/extras/big-question/the-big-question-should-mothers-be-offered-screening-for-autism-and-what-issues-would-it-raise-1332040.html  (17 December 2010).

LAURANCE, J.2009. Autism: study finds 12-fold rise in cases - health news, health & families. The Independent.[online newspaper]. http://www.independent.co.uk/life-style/health-and-families/health-news/autism-study-finds-12fold-rise-in-cases-1692556.html  (17 December 2010).

LE COUTEUR, A. 2003. National autism plan for children (NAPC): plan for the identification, assessment, diagnosis and access to early interventions for pre-school and primary school aged children with autism spectrum disorders (ASD) . 1 edn. London: National Autistic Society.

LE COUTEUR, A., BAILEY, A., GOODE, S., PICKLES, A., ROBERTSON, S., GOTTESMAN, I. and RUTTER, M. 1996. A broader phenotype of autism: the clinical spectrum in twins. Journal of child psychology and psychiatry, and allied disciplines, 37(7), 785-801.

LESHIN, L. Prenatal testing for Down syndrome. http://www.ds-health.com/prenatal.htm (16 December 2010).

LEWIS, S. 2005. Autistic boy, 5, dies after US therapy.Times Online. [Online Newspaper]. http://www.timesonline.co.uk/tol/news/uk/article559318.ece  (28 December 2010).

LORD, C. and CORSELLO, C. 2005. Diagnostic Instruments in Autistic Spectrum Disorders . In: F. VOLKMAR, R. PAUL, A. KLIN and D. COHEN, eds, Handbook of Autism and Pervasive Development Disorders: vol : II. 3 edn. Hoboken, New Jersey: Wiley, pp. 730-731-771.

MADSEN, K., HVIID, A., VESTERGAARD, M., SCHENDEL, D., WOHLFAHRT, J., THORSEN, P., OLSEN, J. and MELBYE, M. 2002. MMR vaccination and autism--a population-based follow-up study. Ugeskrift for laeger, 164(49), 5741-5744.

MADSEN, K. and VESTERGAARD, M. 2004. MMR vaccination and autism : what is the evidence for a causal association? Drug Safety: An International Journal Of Medical Toxicology And Drug Experience, 27(12), 831-840.

MATÉ, G. 2001. When the body says no: Exploring the Stress-Disease Connection.2 edn. United States of America, New Jersey. John Wiley & Sons, Inc.

MCCARTHY, J.2010. Jenny McCarthy's generation rescue. [WWW]. http://www.generationrescue.org/  (13 December 2010).

MCCRAE, F. and WILKES, D. Doctor at centre of MMR row Andrew Wakefield faces being struck off after GMC ruling | Mail online.[online newspaper]. http://www.dailymail.co.uk/news/article-1246775/Doctor-centre-MMR-row-Andrew-Wakefield-faces-struck-GMC-ruling.html  (27 December 2010).

MCTAGGART, L. 2000. The Vaccination Bible: What Doctors don't tell you. 1 edn. London, UK: What Doctors Don't Tell You Limited.

MEDICAL RESEARCH COUNCIL (MRC). 2001. [WWW]. MRC Review of Autism Research: Epidemiology and Causes. http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC002394  (27 December 2010)

MILLER, E. 2003. Measles-mumps-rubella vaccine and the development of autism. Seminars in pediatric infectious diseases, 14(3), 199-206.

MUHLE, R., TRENTACOSTE, S.V. and RAPIN, I. 2004. The genetics of autism. Pediatrics, 113(5), e472-86.

MUTTER, J., NAUMANN, J., SCHNEIDER, R., WALACH, H. and HALEY, B. 2005. Mercury and autism: accelerating evidence? Neuro endocrinology letters, 26(5), 439-446.

NATIONAL AUTISTIC SOCIETY (NAS).2010. How many people have autistic spectrum disorders? [WWW]. http://www.autism.org.uk/about-autism/some-facts-and-statistics/statistics-how-many-people-have-autism-spectrum-disorders.aspx  (16 December 2010).

NATIONAL AUTISTIC SOCIETY (NAS).2010 What are autism and asperger syndrome? [WWW]. http://www.nas.org.uk/nas/jsp/polopoly.jsp?d=2493  (17 February 2010).

NATIONAL AUTISTIC SOCIETY (NAS).2010. The genetics of autism spectrum disorder.[WWW]. http://www.autism.org.uk/working-with/health/screening-and-diagnosis/the-genetics-of-autism-spectrum-disorders.aspx  (6 November 2010).

NATIONAL AUTISTIC SOCIETY (NAS).2010. Position statement: MMR vaccine and autism - NAS.[WWW]. http://www.autism.org.uk/en-gb/news-and-events/media-centre/position-statements/position-statement-mmr-vaccine-and-autism.aspx  (3 December 2010).

NELSON, K.B. and BAUMAN, M.L. 2003. Thimerosal and Autism? Pediatrics, 111(3), 674.

NURMI, E., DOWD, M., TADEVOSYAN-LEYFER, O., HAINES, J., FOLSTEIN, S., SUTCLIFFE,J. 2003. Exploratory [subsetting] of autistic families based on savant skills improves evidence of linkage to 15q11-13. Journal of the American Academy of Child and Adolescent Psychiatry, 42(7), 856-863.

O'DELL, L. and BROWNLOW, C. 2005. Media reports of links between MMR and autism: a discourse analysis. British Journal of Learning Disabilities, 33(4), 194-199.

OFFIT, P. 2010. Autism's False Prophets: bad science, risky medicine, and a search for a cure. 2 edn. USA: Columbia University Press.

OLMSTEAD, D., HANDLEY, J. and BLAXILL, M.2009. Paul Offit: the vaccine industry's most well paid spokesperson.[WWW]. http://www.pauloffit.com/  (13 December 2010).

OLMSTEAD, D., STAGLIANO, K. and BLAXILL, M.2010. A short form FAQ about the Wakefield GMC case. [WWW]. http://www.ageofautism.com/2010/01/a-short-form-faq-about-the-wakefield-gmc-case.html  (6 December 2010).

OLMSTEAD, D., STAGLIANO, K. and BLAXILL, M.2010. , come support Dr. Andrew Wakefield at NBC's today show! - AGE OF AUTISM.[WWW]. http://www.ageofautism.com/2010/05/come-support-dr-andrew-wakefield-at-nbcs-today-show-this-monday.html  (6 December 2010).

PARKER, S.K., SCHWARTZ, B., TODD, J. and PICKERING, L.K. 2004. Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data. Pediatrics, 114(3), 793-804.

PINTO, D., PAGNAMENTA, A.T., KLEI, L., ANNEY, R., MERICO, D., REGAN, R., CONROY, J., MAGALHAES, T.R., CORREIA, C., ABRAHAMS, B.S., ALMEIDA, J., BACCHELLI, E., BADER, G.D., BAILEY, A.J., BAIRD, G., BATTAGLIA, A., BERNEY, T., BOLSHAKOVA, N., BOLTE, S., BOLTON, P.F., BOURGERON, T., BRENNAN, S., BRIAN, J., BRYSON, S.E., CARSON, A.R., CASALLO, G., CASEY, J., CHUNG, B.H., COCHRANE, L., CORSELLO, C., CRAWFORD, E.L., CROSSETT, A., CYTRYNBAUM, C., DAWSON, G., DE JONGE, M., DELORME, R., DRMIC, I., DUKETIS, E., DUQUE, F., ESTES, A., FARRAR, P., FERNANDEZ, B.A., FOLSTEIN, S.E., FOMBONNE, E., FREITAG, C.M., GILBERT, J., GILLBERG, C., GLESSNER, J.T., GOLDBERG, J., GREEN, A., GREEN, J., GUTER, S.J., HAKONARSON, H., HERON, E.A., HILL, M., HOLT, R., HOWE, J.L., HUGHES, G., HUS, V., IGLIOZZI, R., KIM, C., KLAUCK, S.M., KOLEVZON, A., KORVATSKA, O., KUSTANOVICH, V., LAJONCHERE, C.M., LAMB, J.A., LASKAWIEC, M., LEBOYER, M., LE COUTEUR, A., LEVENTHAL, B.L., LIONEL, A.C., LIU, X.Q., LORD, C., LOTSPEICH, L., LUND, S.C., MAESTRINI, E., MAHONEY, W., MANTOULAN, C., MARSHALL, C.R., MCCONACHIE, H., MCDOUGLE, C.J., MCGRATH, J., MCMAHON, W.M., MERIKANGAS, A., MIGITA, O., MINSHEW, N.J., MIRZA, G.K., MUNSON, J., NELSON, S.F., NOAKES, C., NOOR, A., NYGREN, G., OLIVEIRA, G., PAPANIKOLAOU, K., PARR, J.R., PARRINI, B., PATON, T., PICKLES, A., PILORGE, M., PIVEN, J., PONTING, C.P., POSEY, D.J., POUSTKA, A., POUSTKA, F., PRASAD, A., RAGOUSSIS, J., RENSHAW, K., RICKABY, J., ROBERTS, W., ROEDER, K., ROGE, B., RUTTER, M.L., BIERUT, L.J., RICE, J.P., SALT, J., SANSOM, K., SATO, D., SEGURADO, R., SEQUEIRA, A.F., SENMAN, L., SHAH, N., SHEFFIELD, V.C., SOORYA, L., SOUSA, I., STEIN, O., SYKES, N., STOPPIONI, V., STRAWBRIDGE, C., TANCREDI, R., TANSEY, K., THIRUVAHINDRAPDURAM, B., THOMPSON, A.P., THOMSON, S., TRYFON, A., TSIANTIS, J., VAN ENGELAND, H., VINCENT, J.B., VOLKMAR, F., WALLACE, S., WANG, K., WANG, Z., WASSINK, T.H., WEBBER, C., WEKSBERG, R., WING, K., WITTEMEYER, K., WOOD, S., WU, J., YASPAN, B.L., ZURAWIECKI, D., ZWAIGENBAUM, L., BUXBAUM, J.D., CANTOR, R.M., COOK, E.H., COON, H., CUCCARO, M.L., DEVLIN, B., ENNIS, S., GALLAGHER, L., GESCHWIND, D.H., GILL, M., HAINES, J.L., HALLMAYER, J., MILLER, J., MONACO, A.P., NURNBERGER JR, J.I., PATERSON, A.D., PERICAK-VANCE, M.A., SCHELLENBERG, G.D., SZATMARI, P., VICENTE, A.M., VIELAND, V.J., WIJSMAN, E.M., SCHERER, S.W., SUTCLIFFE, J.S. and BETANCUR, C. 2010. Functional impact of global rare copy number variation in autism spectrum disorders Nature.[Online journal]. 466(7304), 368-372.

RAMSAY, S. 2002. UK government tries to control MMR panic. Lancet, 359(9306), 590.

REED, P. OSBORNE, L.2012.Diagnostic practice and its impacts on parental health and child behavour problems in autism spectrum disorders. Archives of Disease in Childhood, 97 (10).pp.927-931

REED, P. OSBORNE, L.2012b.Impact of Severity of autism and intervention time-input on child out-comes: comparison across several early interventions. British Journal of Special Education, 39 (3).pp.130-136

RIMLAND, B. 1998. Vaccinations; The overlooked Factors. Autism Research Review International, 12(1), 1-2,3,6.

RIMLAND, B. 2000. Testimony of Bernard Rimland.[WWW]. http://www.whale.to/v/rimland.html  (16 March 2010).

RONALD, A., HAPPÉ, F. and PLOMIN, R. 2005. The genetic relationship between individual differences in social and nonsocial behaviours characteristic of autism. Developmental Science, 8(5), 444-458.

ROTH, I., BARSON, C., HOEKSTRA, R., PASCO, G. and WHATSON, T., eds. 2010. The Autism Spectrum in the 21st Century:Exploring Psychology, Biology and Practice. 1 edn. United Kingdom and United States of America: Jessica Kingsley in association with The Open University.

RUTTER, M. 2005. Aetiology of autism: findings and questions. Journal of Intellectual Disability Research, 49(4), 231-238.

SAFEMINDS (SENSIBLE ACTION FOR ENDING MERCURY INDUCED NEUROLOGICAL DISORDERS). 2010. Autism Mercury Thimerosal - Executive board.[WWW]. http://www.safeminds.org/about/executive-board.html  (13 December 2010).

SHAO, Y., CUCCARO, M.L., HAUSER, E.R., RAIFORD, K.L., MENOLD, M.M., WOLPERT, C.M., RAVAN, S.A., ELSTON, L., DECENA, K., DONNELLY, S.L., ABRAMSON, R.K., WRIGHT, H.H., DELONG, G.R., GILBERT, J.R. and PERICAK-VANCE, M. 2003. Fine Mapping of Autistic Disorder to Chromosome 15q11-q13 by Use of Phenotypic Subtypes. American Journal of Human Genetics, 72(3), 539.

SHATTOCK, P., WHITELEY, P. and SAVERY, D. 2001. Autism as a Metabolic Disorder: Guidelines for Gluten and Casein-free Dietary Intervention. 2 edn. University of Sunderland, UK.: University of Sunderland, UK.

SHATTOCK, P. and WHITELEY, P. 1999. MMR and Autism: C. Gillberg & H. Heijdal, Autism, 1998, 2(4), 423-4. Autism: The International Journal of Research & Practice, 3(1), 111.

SINGH, V.K. 2009. Phenotypic expression of autoimmune autistic disorder (AAD): a major subset of autism. United States: .

SINGH, V.K., LIN, S.X., NEWELL, E. and NELSON, C. 2002. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. Journal of Biomedical Science, 9(4), 359-364.

SMEETH, L., COOK, C., FOMBONNE, E., HEAVEY, L., RODRIGUES, L.C., SMITH, P.G. and HALL, A.J. 2004. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet, 364(9438), 963-969.

SMITH, L.2005. Autistic boy, 5, dies after US therapy. Times online.[online newspaper]. http://www.timesonline.co.uk/tol/news/uk/article559318.ece  (20 December 2010).

SOUZA, A.2010.I am a person not a disease. [WWW]. http://www.mouthmag.com/issues/78/30_souza.html  (16 November 2010).

STONE, J.2010. Dr. Wakefield, MMR & the GMC hearing – calling the British Media’s bluff. [WWW]. http://www.ageofautism.com/2010/01/dr-wakefield-mmr-the-gmc-hearing-calling-the-british-medias-bluff.html  (6 December 2010).

SZATMARI, P., PATERSON, A.D., ZWAIGENBAUM, L., ROBERTS, W., BRIAN, J., LIU, X., VINCENT, J.B., SKAUG, J.L., THOMPSON, A.P., SENMAN, L., FEUK, L., QIAN, C., BRYSON, S.E., JONES, M.B., MARSHALL, C.R., SCHERER, S.W., VIELAND, V.J., BARTLETT, C., MANGIN, L.V., GOEDKEN, R., SEGRE, A., PERICAK-VANCE, M., CUCCARO, M.L., GILBERT, J.R., WRIGHT, H.H., ABRAMSON, R.K., BETANCUR, C., BOURGERON, T., GILLBERG, C., LEBOYER, M., BUXBAUM, J.D., DAVIS, K.L., HOLLANDER, E., SILVERMAN, J.M., HALLMAYER, J., LOTSPEICH, L., SUTCLIFFE, J.S., HAINES, J.L., FOLSTEIN, S.E., PIVEN, J., WASSINK, T.H., SHEFFIELD, V., GESCHWIND, D.H., BUCAN, M., BROWN, W., CANTOR, R.M., CONSTANTINO, J.N., GILLIAM, C., HERBERT, M., LAJONCHERE, C., LEDBETTER, D.H., LESE-MARTIN, C., MILLER, J., NELSON, S., SAMANGO-SPROUSE, C., SPENCE, S., STATE, M., TANZI, R.E., COON, H., DAWSON, G., DEVLIN, B., ESTES, A., FLODMAN, P., KLEI, L., MCMAHON, W.M., MINSHEW, N., MUNSON, J., KORVATSKA, E., RODIER, P.M., SCHELLENBERG, G.D., SMITH, M., SPENCE, M., STODGELL, C., TEPPER, P.G., WIJSMAN, E.M., YU, C., ROGÉ, B., MANTOULAN, C., WITTEMEYER, K., POUSTKA, A., FELDER, B., KLAUCK, S.M., SCHUSTER, C., POUSTKA, F., BÖLTE, S., FEINEIS-MATTHEWS, S., HERBRECHT, E., SCHMÖTZER, G., TSIANTIS, J., PAPANIKOLAOU, K., MAESTRINI, E., BACCHELLI, E., BLASI, F., CARONE, S., TOMA, C., VAN ENGELAND, H., DE JONGE, M., KEMNER, C., KOOP, F., LANGEMEIJER, M., HIJMANS, C., STAAL, W.G., BAIRD, G., BOLTON, P.F., RUTTER, M.L., WEISBLATT, E., GREEN, J., ALDRED, C., WILKINSON, J., PICKLES, A., LE COUTEUR, A., BERNEY, T., MCCONACHIE, H., BAILEY, A.J., FRANCIS, K., HONEYMAN, G., HUTCHINSON, A., PARR, J.R., WALLACE, S., MONACO, A.P., BARNBY, G., KOBAYASHI, K., LAMB, J.A., SOUSA, I., SYKES, N., COOK, E.H., GUTER, S.J., LEVENTHAL, B.L., SALT, J., LORD, C., CORSELLO, C., HUS, V., WEEKS, D.E., VOLKMAR, F., TAUBER, M., FOMBONNE, E., SHIH, A. and MEYER, K.J. 2007. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature genetics, 39(3), 319-328.

TAYLOR, B., MILLER, E., LINGAM, R., ANDREWS, N., SIMMONS, A. and STOWE, J. 2002. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ (Clinical research ed.), 324(7334), 393-396.

TEMPLETON, S.2010.Doctors want to screen out embryos with autism.[WWW]. http://www.aspiesforfreedom.com/showthread.php?tid=4038&pid=48709  (16 November 2010).

TER HORST, G.J. 2010. Estrogen in the limbic system. Vitamins and hormones, 82, 319-338.

THE CADHERIN RESOURCE. 2002. Introduction to cadherins. [WWW]. http://calcium.uhnres.utoronto.ca/cadherin/pub_pages/general/intro_cadherins.htm  (06 January 2010).

THE CHILDRENS HOSPITAL OF PHILADEPHIA (CHOP).2010. , Paul A. Offit | the children's hospital of Philadelphia.[WWW]. http://www.chop.edu/doctors/offit-paul-a.html  (13 December 2010).

THE LANCET 2000. Measles, MMR, and autism: the confusion continue: An Editorial. Lancet, 355(9213), 1379.

THE LANCET. 2010. 2010. Autism Retraction [WWW]. Education Week, 29(21), 5-5.

THROWER, D., HARVEY, P. and MURCH, S. 2004. MMR and autism: the debate continues. Lancet, 363(9408), 567-568.

TOMMEY, P. 2010. The Autism File Global | About. The Autism File Global, 2010(12/18/2010),.

TOMMEY, P.2010. Andrew Wakefield speaks at parliament on autism.[video podcast]. http://autismfile.com/media/videos/the-frontier/andrew-wakefield-speaks-at-parliament-on-autism/  (12 December 2010).

TREATING AUTISM.2010. Autism is treatable.[WWW]. http://www.treatingautism.co.uk/about-us/  (18 December 2010).

UCHIYAMA, T., KUROSAWA, M. and INABA, Y. 2007. MMR-vaccine and regression in autism spectrum disorders: negative results presented from Japan. Journal of Autism and Developmental Disorders, 37(2), 210-217.

WAKEFIELD, A. 2010. Callous Disregard: Autism and Vaccines - The truth behind a Tragedy. 1 edn. USA: Sky Horse Publishing.

WALY, M., OLTEANU, H., BANERJEE, R., CHOI, S.-., MASON, J.B., PARKER, B.S., SUKUMAR, S., SHIM, S., SHARMA, A., BENZECRY, J.M., POWER-CHARNITSKY, V. and DETH, R.C. 2004. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Molecular psychiatry, 9(4), 358-370.

WANG, K.; ZHANG, H.; MA, D.; BUCAN, M.; GLESSNER, J.; ABRAHAMS, B.; SALYAKINA, D.; IMIELINSKI, M.; BRADFIELD, J.; SLEIMAN P.; KIM,C.; HOU,C.; FRACKELTON, E.; CHIAVACCI, R.; TAKAHASHI, N.; SAKURAI, T.; RAPPAPORT, E.; LAJONCHERE, C.; MUNSON, J.; ESTES, A.; KORVATSKA, O.; PIVEN, J.; SONNENBLICK, L.; ALVAREZ, R., ANA, I.; HERMAN, E.; DONG, H.; HUTMAN, T.; SIGMAN, M.; OZONOFF, S.; KLIN, A.; OWLEY, T.; SWEENEY, J.; BRUNE, C.; CANTOR, R.; BERNIER, R.; GILBERT, J.; CURRACO, M.; MCMAHON, W.; MILLER, J.; STATE, M.; WASSINK, T.; COON, H.; LEVY, S.; SCHULTZ, R.; NURNBERGER, J.; HAINES, J.; SUTCLIFFE, J.; COOK, E.; MINSHEW, N.; BUXBAUM, J.; DAWSON, G.; GRANT, S.; GESCHWIND, D.; PERICAK-VANCE, M.; SCHELLENBERG, G.; HAKONARSON, H. 2009. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature, 459(7246), 528-533.

 

WATTS, G. 2004. The new MMR? BMJ: British Medical Journal, 328(7442), 773-773.

WEISS, L. and LARKING, D. 2009. A Genome-wide linkage and association scan reveals novel loci for autism. Nature, 461, 802-803-811.

WING, L., GILLBERG, C., ROZAGY., SMITH, J. and HARDER, M. 2010. Autism in Women and Girls, L. WING, C. GILLBERG, ROZAGY., J. SMITH and M. HARDER, eds. In: 03/27/2010 2010, Research Autism.

WORLD HEALTH ORGANISATION (WHO). 2006. WHO | Thiomersal and vaccines: questions and answers.[WWW]. http://www.who.int/vaccine_safety/topics/thiomersal/questions/en/  (18 December 2010).

WORLD HEALTH ORGANIZATION 1992. The ICD-10 classification of mental and behavioural disorders : clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.